Creating meaningful science-based advances for our partners and the patients they care for.

At Tolmar, we seize the opportunity to innovate at every step. From scientific breakthroughs to innovation in patient and office support and services, we strive to bring both traditional genius and modern creativity to our work. This mindset enables Tolmar to continually deliver innovative therapies and inventive solutions tailored for our customers and partners.
 
We believe in the importance of scientific data to better understand and demonstrate the clinical relevance and efficacy of our products. Tolmar actively participates broadly across local, regional and national forums where clinical data is exchanged and discussed.

The proprietary ATRIGEL® Delivery System contained within ELIGARD® (leuprolide acetate for injectable suspension) is a unique formulation technology designed to deliver a continuous dose of medicine over an extended period of time. This makes it possible for patients and their physicians to choose the most suitable dosing schedule, while ensuring consistent, predictable delivery of targeted therapy doses. 
 
TolmarSync®, our proprietary practice and patient management platform sets a new standard for technology-based solutions that optimize, track, report and manage inventory. TolmarSync integrates our in-office delivered therapies into office practice processes, ensuring optimized product availability and on-time scheduling for patient injections.

Discover Tolmar’s flagship treatment, ELIGARD® (leuprolide acetate for injectable suspension).

Explore Tolmar’s other innovative products.